Showing results (1581-1590 of 1,628) with videos related to
Sort By:
Pageof 163
Blood|June 25, 2025
IPSS-M risk and specific sex-associated somatic mutations predict response to ESA therapy in LR-MDS: building a new scoreMarco G Raddi, Sophie Park, Michaela Fontenay, et al.American Journal of Hematology|June 20, 2024
Outcomes of acute myeloid leukemia patients who responded to venetoclax and azacitidine and stopped treatmentSylvain Garciaz, Pierre-Yves Dumas, Sarah Bertoli, et al.Blood Advances|October 30, 2023
Timing of anti-PD-L1 antibody initiation affects efficacy/toxicity of CD19 CAR T-cell therapy for large B-cell lymphomaAlexandre V Hirayama, Erik L Kimble, Jocelyn H Wright, et al.American Journal of Hematology|July 4, 2026
High Proportion of PNH Type II Neutrophils Is Associated With Thrombosis in Patients Displaying a PNH Clone ≥ 1Orianne Wagner-Ballon, Anne-Catherine Lhoumeau, Anna Raimbault, et al.Research Square|October 20, 2022
CD8+ T cell clonotypes from prior SARS-CoV-2 infection predominate during the cellular immune response to mRNA vaccinationEmily S Ford, Koshlan Mayer-Blackwell, Lichen Jing, et al.Blood|February 8, 2019
Factors associated with durable EFS in adult B-cell ALL patients achieving MRD-negative CR after CD19 CAR T-cell therapyKevin A Hay, Jordan Gauthier, Alexandre V Hirayama, et al.Molecular Psychiatry|February 11, 2009
Transcriptomic and genetic studies identify IL-33 as a candidate gene for Alzheimer's diseaseJ Chapuis, D Hot, F Hansmannel, et al.Blood|September 23, 2020
Factors associated with outcomes after a second CD19-targeted CAR T-cell infusion for refractory B-cell malignanciesJordan Gauthier, Evandro D Bezerra, Alexandre V Hirayama, et al.Nature Communications|January 3, 2026
A CD8αβ co-receptor modified to contain an intracellular CD28 signaling tail enhances TCR-engineered T cell function independent of solid-tumor-associated co-stimulatory ligandsShihong Zhang, Tzu-Hao Tang, Sinéad Kinsella, et al.Blood|April 29, 2024
HA-1-targeted T-cell receptor T-cell therapy for recurrent leukemia after hematopoietic stem cell transplantationElizabeth F Krakow, Michelle Brault, Corinne Summers, et al.Pageof 163